A5062621995- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Myasthenia Gravis and Thymoma
- Clinical Laboratory Practices and Quality Control
- Sepsis Diagnosis and Treatment
- Biotin and Related Studies
- Blood Coagulation and Thrombosis Mechanisms
- SARS-CoV-2 and COVID-19 Research
- Atrial Fibrillation Management and Outcomes
- Childhood Cancer Survivors' Quality of Life
- Hemodynamic Monitoring and Therapy
- Blood properties and coagulation
- Ion channel regulation and function
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Dialysis and Renal Disease Management
- Electrolyte and hormonal disorders
- Blood transfusion and management
- Acute Lymphoblastic Leukemia research
Université Libre de Bruxelles
2023
AZ Sint-Jan
2022
Universitair Ziekenhuis Brussel
2021
Vrije Universiteit Brussel
2021
Cliniques Universitaires Saint-Luc
2020
UCLouvain
2020
Abstract Objectives As severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic is increasing its victims on a global scale with recurring outbreaks, it remains of outmost importance to rapidly identify people requiring an intensive care unit (ICU) hospitalization. The aim this study was Coronavirus Disease 2019 (COVID-19) biomarkers, investigate their correlation disease severity and evaluate usefulness for follow-up. Methods Fifty patients diagnosed SARS-Cov-2 were included in...
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in the general population context a relatively high immunity gained through early waves disease 19 (COVID-19), and vaccination campaigns. Despite this context, significant number patients were hospitalized, identifying risk factors associated with era is critical for targeting further preventive, curative interventions. We retrospectively analyzed individual medical records 1501 SARS-CoV-2 positive...
When using indirect ion-selective electrode (ISE) methods, hypertriglyceridemia leads to pseudohyponatremia due water displacement artifacts. Multiple strategies exist minimize this interference. Our objective was create a patient-friendly one-tube-fits-all testing setup without compromising the method robustness.Four were evaluated in single patient with hypertriglyceridemia. Additionally, interchangeability between Cobas 8000 and ABL Flex on samples (n = 2274) different total protein (TP)...
Topic: 33. Bleeding disorders (congenital and acquired) Background: Exploring fibrinolysis has always been time-consuming, difficult incomplete because of a lack easy available tests. The Lysis timer® (LT), device developed by Biophen, is designed to determine the global capacity (GFC) patients. With provide results in less than 1 hour. GFC/LT tests dissolution plasma clot, obtained addition thrombin calcium, presence silica defined amount exogenous tissue plasminogen activator (tPA). Aims:...
Topic: 33. Bleeding disorders (congenital and acquired) Background: Tranexamic acid (TXA), an anti-fibrinolytic drug, can be used to reduce blood loss transfusion need in surgery trauma situations. However, overdosing of TXA lead hypofibrinolysis thus a pro-coagulant state. Previous research has demonstrated the possibility evaluate dose-effect response with thromboelastography. The Lysis timer® (LT), device developed by Biophen, is designed determine global fibrinolysis capacity (GFC)...
Body fluid cell counting and differentiation provide essential information for diagnosis monitoring of diverse pathologies. We evaluated the performance newly launched Abbott Alinity hq hematology analyzer automated in body fluids compared red blood (RBC) total nucleated (TNC) counts with Cell-Dyn Sapphire analyzer. Differential were microscopic on cytocentrifuged preparations.Background concentration limits, limit detection (LOD), linearity, imprecision, functional sensitivity carryover...